title: Development of a new psychosocial treatment for adult ADHD.
abstract: OBJECTIVE
  The purpose of this study was to assess the effectiveness of a new manualized group Meta-Cognitive Therapy (MCT) for adults with ADHD that extends the principles and practices of cognitive-behavioral therapy to the development of executive self-management skills.
  
  
  METHODS
  Thirty adults diagnosed with ADHD completed an 8- or 12-week program designed to target impairments in time management, organization, and planning skills. Treatment efficacy was measured using pre- and posttreatment self-report standardized measures (CAARS-S:L & Brown ADD Scales).
  
  
  RESULTS
  General linear modeling revealed a robust significant posttreatment decline on the CAARS DSM-IV Inattentive symptom scale (p < .001) as well as improvement on the Brown ADD Scales (p < .001).
  
  
  CONCLUSIONS
  The findings indicate that participants in the MCT program showed marked improvement with respect to core ADHD symptoms of inattention, as well as executive functioning skills, suggesting that this program has promise as a treatment for meta-cognitive deficits in adults with ADHD.
authors: Department of Psychiatry, ADHD Center, Mount Sinai School of Medicine, New York, NY 10029-6574, USA. mary.solanto@mssm.edu
authors: Mary V
authors: MV
authors: Solanto
authors: David J
authors: DJ
authors: Marks
authors: Katherine J
authors: KJ
authors: Mitchell
authors: Jeanette
authors: J
authors: Wasserstein
authors: Michele D
authors: MD
authors: Kofman
mesh_terms: D000328:Adult; D000368:Aged; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy / Q000453:epidemiology / Q000628:therapy*; D001290:Attitude; D015928:Cognitive Behavioral Therapy / Q000379:methods*; D015897:Comorbidity; D003866:Depressive Disorder / Q000188:drug therapy / Q000453:epidemiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D016730:Program Development; D011584:Psychology; D011619:Psychotropic Drugs / Q000627:therapeutic use; D013998:Time Perception
chemical_list: D011619:Psychotropic Drugs